EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation

Zheqi Cai, Zhiyun Hong, Guohui Zhang, Tinwei Zhu, Yanrong Zhou iD, Ting Ye, Gongchu Li, Kan Chen

Viruses · 27.10.2025 · 17 (11) · 1423

DOI: 10.3390/v17111423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 27.10.2025. Verfasst von Zheqi Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. Hauptthemen laut MEDLINE: HSP70 Heat-Shock Proteins, Ovarian Neoplasms, Vaccinia virus, Oncolytic Viruses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heat shock protein 70 (HSP70) represents a promising target for cancer therapy. Oncolytic vaccinia virus (oncoVV) mediates tumor regression through direct oncolysis and immune activation. However, the anti-tumor potential of HSP70-silenced oncoVV (oncoVV-shHSP70) remains unexplored. Here, we demonstrate that oncoVV-shHSP70 achieves superior tumor regression in ovarian cancer models (cell lines, immunodeficient mice and humanized mice) via dual mechanisms including enhancing apoptosis, autophagy flux, ROS generation, and immune reprogramming. Notably, we found that oncoVV-shHSP70 triggers an autophagy–ROS feedback loop that amplifies viral replication and pro-inflammatory cytokine expression. Crucially, in humanized mice, oncoVV-shHSP70 induced spatial redistribution of cytotoxic T cells, expanding tumor-infiltrating hCD8+hGZMB+ populations. These findings position oncoVV-shHSP70 as a promising viro-immunotherapy that co-opts HSP70 silencing to potentiate both direct oncolysis and anti-tumor immunity, providing a preclinical rationale for viro-immunotherapy in solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP70 Heat-Shock ProteinsOvarian NeoplasmsVaccinia virusOncolytic VirusesAutophagyOncolytic VirotherapyRNA, Small InterferingReactive Oxygen SpeciesFemaleAnimalsHumansMiceCell Line, TumorVirus ReplicationApoptosis

Stichwörter der Autor:innen

ROS-autophagy feedbackhumanized mouse modelimmune activationoncoVV-shHSP70ovarian cancer

Substanzen

HSP70 Heat-Shock ProteinsRNA, Small InterferingReactive Oxygen Species

Autor:innen und Institutionen

  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.

ORCID-Profile: Yanrong Zhou

Förderung

  • National Natural Science Foundation of China
  • the National Natural Science Foundation of China

Zitieren

APA

Cai, Z., Hong, Z., Zhang, G., Zhu, T., Zhou, Y., Ye, T., Li, G., & Chen, K. (2025). Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation. Viruses, 17(11), 1423. https://doi.org/10.3390/v17111423

Vancouver

Cai Z, Hong Z, Zhang G, Zhu T, Zhou Y, Ye T, et al. Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation. Viruses. 2025;17(11):1423. doi:10.3390/v17111423

BibTeX
@article{Cai2025,
  author = {Cai, Zheqi and Hong, Zhiyun and Zhang, Guohui and Zhu, Tinwei and Zhou, Yanrong and Ye, Ting and Li, Gongchu and Chen, Kan},
  title = {Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {11},
  pages = {1423},
  doi = {10.3390/v17111423}
}
Kostenlos starten →